Document Type

Patent

Publication Date

9-2-2025

Abstract

The present invention provides collagen-binding agents that can be used to treat wounds, ischemic heart disease, and other conditions. The collagen-binding agents comprise a therapeutic agent, a protease cleavage site, and a collagen-binding domain. The present invention further provides pharmaceutical compositions and biomedical devices comprising the disclosed collagen-binding agents, as well as methods for treating a condition using the collagen-binding agents.

Department

Chemical Engineering; Chemistry & Biochemistry

Patent Number

US12403179

Application Number

US 20220257715

Application Published

8-18-2022

Application Filed

2-18-2022

Assignee

Board of Trustees of the University of Arkansas (Little Rock, AR); National University Corporation Okayama University (Okayama, JP)

Comments

Joshua Sakon, Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR
Robert Beitle, Department of Chemical Engineering, University of Arkansas, Fayetteville, AR
Hazim S. Aljewari, Department of Chemical Engineering, University of Arkansas, Fayetteville, AR
Stephanie Beitle, Department of Chemical Engineering, University of Arkansas, Fayetteville, AR

Share

COinS